30 July 2024 in Biomaterials
6 May 2022 in Science Advances
Protozoan parasites that infect humans are widespread and lead to varied clinical manifestations, including life-threatening illnesses in immunocompromised individuals. Animal models have provided insight into innate immunity against parasitic infections; however, species-specific differences and complexity of innate immune responses make translation to humans challenging. Thus, there is a need for in vitro systems that can elucidate mechanisms of immune control and parasite dissemination. We have developed a human microphysiological system of intestinal tissue to evaluate parasite-immune–specific interactions during infection, which integrates primary intestinal epithelial cells and immune cells to investigate the role of innate immune cells during epithelial infection by the protozoan parasite, Toxoplasma gondii , which affects billions of people worldwide. Our data indicate that epithelial infection by parasites stimulates a broad range of effector functions in neutrophils and natural killer cell–mediated cytokine production that play immunomodulatory roles, demonstrating the potential of our system for advancing the study of human-parasite interactions.
29 November 2023 in bioRxiv
Tumor-associated inflammation drives cancer progression and therapy resistance, with the infiltration of monocyte-derived tumor-associated macrophages (TAMs) associated with poor prognosis in diverse cancers. Targeting TAMs holds potential against solid tumors, but effective immunotherapies require testing on immunocompetent human models prior to clinical trials. Here, we develop an in vitro model of microvascular networks that incorporates tumor spheroids or patient tissues. By perfusing the vasculature with human monocytes, we investigate monocyte trafficking into the tumor and evaluate immunotherapies targeting the human tumor microenvironment. Our findings demonstrate that macrophages in vascularized breast and lung tumor models can enhance monocyte recruitment via TAM-produced CCL7 and CCL2, mediated by CSF-1R. Additionally, we assess a novel multispecific antibody targeting CCR2, CSF-1R, and neutralizing TGF-β, referred to as CSF1R/CCR2/TGF-β Ab, on monocytes and macrophages using our 3D models. This antibody repolarizes TAMs towards an anti-tumoral M1-like phenotype, reduces monocyte chemoattractant protein secretion, and effectively blocks monocyte migration. Finally, we show that the CSF1R/CCR2/TGF-β Ab inhibits monocyte recruitment in patient-specific vascularized tumor models. Overall, this vascularized tumor model offers valuable insights into monocyte recruitment and enables functional testing of innovative therapeutic antibodies targeting TAMs in the tumor microenvironment (TME).
1 December 2025 in Advanced Materials Technologies
Cell‐lined luminal structures are crucial for nutrient transport, tissue barriers, and paracrine interactions. Modeling these structures is essential for developing accurate in vitro models, but conventional systems struggle with their geometrical complexity. While recent microengineering and self‐assembly platforms have shown promise, they face limitations in throughput, equipment compatibility, and technical complexity. To address these challenges, we have developed an array of 3D tissue constructs with luminal structures that overcome current limitations. The platform employs a sacrificial micromolding technique to generate arrays of luminal structures within extracellular matrix (ECM) hydrogels in a single process, improving throughput. We also incorporate a reconfigurable oil barrier between tissue compartments, enabling dynamic modeling of multi‐tissue interactions. This approach reduces fabrication complexity, increases robustness, and offers high flexibility in arranging multi‐tissue constructs. The platform allows formation of multiple luminal structures and tissue configurations, discrete compartmentalization for parallel experiments, and reconfiguration of the oil barrier to study physiological multi‐tissue interactions. By facilitating complex microtissue cultures and multi‐tissue experiments on a single device, the platform presents a promising technology for multi‐organ modeling research and drug discovery applications.
5 April 2022 in Advanced Science
Autonomously Regulated Oxygen Microenvironments